{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Guo Z"],"funding":["Medical-Scientific-Research-Foundation-of-Guangdong-Province-of-China","Guangdong Provincial International Cooperation Base of Science and Technology","Guangdong Provincial International Cooperation Base of Science and Technology (Organ Transplantation)","MOST | National Natural Science Foundation of China (NSFC)","Science and Technology Program of Guangdong","China organ transplantation development foundation","Guangdong Provincial Key Laboratory of Construction Projection on Organ Donation and Transplant Immunology","MOST | National Natural Science Foundation of China"],"pagination":["2322-2348"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11479250"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["16(10)"],"pubmed_abstract":["Brain injury is the leading cause of mortality among patients who survive cardiac arrest (CA). Clinical studies have shown that the presence of post-CA hypoxic hepatitis or pre-CA liver disease is associated with increased mortality and inferior neurological recovery. In our in vivo global cerebral ischemia model, we observed a larger infarct area, elevated tissue injury scores, and increased intravascular CD45+ cell adhesion in reperfused brains with simultaneous hepatic ischemia than in those without it. In the ex vivo brain normothermic machine perfusion (NMP) model, we demonstrated that addition of a functioning liver to the brain NMP circuit significantly reduced post-CA brain injury, increased neuronal viability, and improved electrocortical activity. Furthermore, significant alterations were observed in both the transcriptome and metabolome in the presence or absence of hepatic ischemia. Our study highlights the crucial role of the liver in the pathogenesis of post-CA brain injury."],"journal":["EMBO molecular medicine"],"pubmed_title":["Liver protects neuron viability and electrocortical activity in post-cardiac arrest brain injury."],"pmcid":["PMC11479250"],"funding_grant_id":["A2020275","82300744","81970564,82170663,82370664","2020B1111140003","2023B1212060020","2020A0505020003","82070670"],"pubmed_authors":["Guo Z","Zhu Y","Sun C","Nashan B","Xu G","Xu J","Zhu C","Wang L","Xie R","Huang S","He S","Li Y","Zhang Z","Gao N","Zhang Y","Zhao Q","Wang T","He X","Yin M","Liu D","Zhan L","Andrea S","Jia Z","Zheng D"],"additional_accession":[]},"is_claimable":false,"name":"Liver protects neuron viability and electrocortical activity in post-cardiac arrest brain injury.","description":"Brain injury is the leading cause of mortality among patients who survive cardiac arrest (CA). Clinical studies have shown that the presence of post-CA hypoxic hepatitis or pre-CA liver disease is associated with increased mortality and inferior neurological recovery. In our in vivo global cerebral ischemia model, we observed a larger infarct area, elevated tissue injury scores, and increased intravascular CD45+ cell adhesion in reperfused brains with simultaneous hepatic ischemia than in those without it. In the ex vivo brain normothermic machine perfusion (NMP) model, we demonstrated that addition of a functioning liver to the brain NMP circuit significantly reduced post-CA brain injury, increased neuronal viability, and improved electrocortical activity. Furthermore, significant alterations were observed in both the transcriptome and metabolome in the presence or absence of hepatic ischemia. Our study highlights the crucial role of the liver in the pathogenesis of post-CA brain injury.","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Oct","modification":"2025-04-04T11:05:33.725Z","creation":"2025-04-04T11:05:33.725Z"},"accession":"S-EPMC11479250","cross_references":{"pubmed":["39300235"],"doi":["10.1038/s44321-024-00140-z"]}}